Cerebrovascular changes in the basal ganglia with HIV dementia

Neurology

Volumn 54, Issue 4, 2000, Pages 921-926

  Berger, Joseph R ^a   Nath, A ^a   Greenberg, R N ^a   Andersen, A H ^a   Greene, R A ^a   Bognar, A ^a   Avison, M J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

AIDS; Basal ganglia; Blood brain barrier; Dementia; HIV; Regional cerebral blood volume

Indexed keywords

ADULT; ARTICLE; BASAL GANGLION; BLOOD BRAIN BARRIER; BRAIN BLOOD VOLUME; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORRELATION FUNCTION; DEMENTIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0034701050     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.4.921     Document Type: Article

References (48)

1. Petito CK, Cash KS. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992;32:658-666.
2. Power C, Kong PA, Crawford TO, et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 1993;34: 339-350.
3. Smith TW, DeGirolami U, Benin D, Bolgert F, Hauw JJ. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol 1990;49: 357-370.
4. McArthur JC, Nance Sproson TE, Griffin DE, et al. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study. Neurology 1992;42:1707-1712.
5. Singer EJ, Syndulko K, Fahy Chandon B, Schmid P, Conrad A, Tourtellotte WW. Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease. J Acquir Immune Defic Syndr 1994;7:265-271.
6. Moses AV, Nelson JA. HIV infection of human brain capillary endothelial cells - implications for AIDS dementia. Adv Neuroimmunol 1994;4:239-247.
7. Rhodes RH. Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome. J Neuropathol Exp Neurol 1991;50:171-183.
8. Berger JR, Nath A. HIV dementia and the basal ganglia. Intervirology 1997;40:122-131.
9. Hinkin CH, van Gorp WG, Mandelkern MA, et al. Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography. J Neuropsychiatry Clin Neurosci 1995;7:180-187.
10. Pavlakis SG, Lu D, Frank Y, et al. Magnetic resonance spectroscopy in childhood AIDS encephalopathy. Pediatr Neurol 1995;12:277-282.
11. Rottenberg DA, Sidtis JJ, Strother SC, et al. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med 1996;37:1133-1141.
12. Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzalez RG. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study [published erratum appears in Neurology 1996;46: 1787]. Neurology 1996;46:783-788.
13. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158:1079-1083.
14. Tracey I, Hamberg LM, Guimaraes AR, et al. Increased cerebral blood volume in HIV-positive patients detected by functional MRI. Neurology 1998;50:1821-1826.
15. Chang L, Speck O, Walot I, Ernst T. Perfusion MRI detects regional cerebral blood flow abnormalities in patients with early stages of HIV dementia (abstract). Neurology 1999; 52(suppl2): A254-A255.
16. Mooradian AD. Potential mechanisms of the age-related changes in the blood-brain barrier. Neurobiol Aging 1994;15: 751-755.
17. Leenders KL, Perani D, Lammertsma AA, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 1990;113:27-47.
18. Mackic JB, Weiss MH, Miao W, et al. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy. J Neurochem 1998;70:210-215.
19. Kalaria RN. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol Ther 1996;72:193-214.
20. Su MY, Head E, Brooks WM, et al. Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging. Neurobiol Aging 1998;19:479-485.
21. Royal W 3rd, Selnes OA, Concha M, Nance Sproson TE, McArthur JC. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-I) p24 antigen levels in HIV-1-related dementia. Ann Neurol 1994;36:32-39.
22. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999;9:1249-1253.
23. Shi B, De Girolami U, He J, et al. Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest 1996;98: 1979-1990.
24. Hofman FM, Dohadwala MM, Wright AD, Hinton DR, Walker SM. Exogenous tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol 1994;54:19-28.
25. Kruman II, Nath A, Mattson MP. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 1998;154:276-288.
26. Adamson DC, Wildemann B, Sasaki M. et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996;274:1917-1921.
27. Conant K, Garzino Demo A, Nath A, et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 1998;95:3117-3121.
28. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19:517-524.
29. Selnes OA, Galai N, Bacellar H, et al. Cognitive performance after progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study. Neurology 1995;45:267-275.
30. Mirsattari SM, Power C, Nath A. Parkinsonism with HIV infection. Mov Disord 1998;13:684-689.
31. Johnston JL, Miller JD, Nath A. Ocular motor dysfunction in HIV-1-infected subjects: a quantitative oculographic analysis. Neurology 1996;46:451-457.
32. Aylward EH, Brettschneider PD, McArthur JC, et al. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry 1995;152:987-994.
33. Jakobsen J, Gyldensted C, Brun B, Bruhn P, Helweg Larsen S, Arlien Soborg P. Cerebral ventricular enlargement relates to neuropsychological measures in unselected AIDS patients. Acta Neurol Scand 1989;79:59-62.
34. Hestad K, McArthur JH, Dal Pan GJ, et al. Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance. Acta Neurol Scand 1993;88:112-118.
35. van Gorp WG, Mandelkern MA, Gee M, et al. Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia. J Neuropsychiatry Clin Neurosci 1992;4:280-287.
36. Berger JR, Kumar M, Kumar A, Fernandez JB, Levin B. Cerebrospinal fluid dopamine in HIV-1 infection. AIDS 1994;8: 67-71.
37. Larsson M, Hagberg L, Forsman A, Norkrans G. Cerebrospinal fluid catecholamine metabolites in HIV-infected patients. J Neurosci Res 1991;28:406-409.
38. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986;19:525-535.
39. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HFV-I brain infection: clinical-virological correlations. Ann Neurol 1995;38:563-570.
40. Rostasy K, Monti L, Yiannoutsos C, et al. Human immunodeficiency virus infection, inducible nitric oxide synthase expression and microglial activation: pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex. Ann Neurol 1999;46:207-216.
41. Wiley CA, Soontornniyomkij V, Radhakrishnan L, et al. Distribution of brain HIV load in AIDS. Brain Pathol 1998;8:277-284.
42. Neuen Jacob E, Arendt G, Wendtland B, Jacob B, Schneeweis M, Wechsler W. Frequency and topographical distribution of CD68-positive macrophages and HIV-1 core proteins in HIV-associated brain lesions. Clin Neuropathol 1993;12:315-324.
43. Reyes MG, Faraldi F, Senseng CS, Flowers C, Fariello R. Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol Berl 1991;82:39-44.
44. Komatsu T, Ireland DD, Chung N, Dor A, Yoder M, Shoshkes Reiss C. Regulation of the BBB during viral encephalitis: roles of IL-12 and NOS. Nitric Oxide 1999;3:327-339.
45. Jaworowicz DJ Jr, Korytko PJ, Singh Lakhman S, Boje KM. Nitric oxide and prostaglandin E2 formation parallels blood-brain barrier disruption in an experimental rat model of bacterial meningitis. Brain Res Bull 1998;46:541-546.
46. Fischer S, Clauss M, Wiesnet M, Renz D, Schaper W, Karliczek GF. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am J Physiol 1999;276: C812-C820.
47. Alm P, Sharma HS, Hedlund S, Sjoquist PO, Westman J. Nitric oxide in the pathophysiology of hyperthermic brain injury. Influence of a new anti-oxidant compound H-290/51. A pharmacological study using immunohistochemistry in the rat. Amino Acids 1998;14:95-103.
48. Sacktor NC, Bacellar H, Hoover DR, et al. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol 1996;2:404-410.